P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.

MLA

Katayama, Ryohei, et al. “P-Glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer.” EBioMedicine, vol. 3, Dec. 2015, pp. 54–66. EBSCOhost, https://doi.org/10.1016/j.ebiom.2015.12.009.

APA

Katayama, R., Sakashita, T., Yanagitani, N., Ninomiya, H., Horiike, A., Friboulet, L., Gainor, J. F., Motoi, N., Dobashi, A., Sakata, S., Tambo, Y., Kitazono, S., Sato, S., Koike, S., John Iafrate, A., Mino-Kenudson, M., Ishikawa, Y., Shaw, A. T., Engelman, J. A., … Fujita, N. (2015). P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer. EBioMedicine, 3, 54–66. https://doi.org/10.1016/j.ebiom.2015.12.009

Chicago

Katayama, Ryohei, Takuya Sakashita, Noriko Yanagitani, Hironori Ninomiya, Atsushi Horiike, Luc Friboulet, Justin F Gainor, et al. 2015. “P-Glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer.” EBioMedicine 3 (December): 54–66. doi:10.1016/j.ebiom.2015.12.009.